Suppliers / Valdepharm

Valdepharm

France Updated 9 July 2026

Valdepharm is an API manufacturer based in France. It holds 6 active US drug master files across a filed portfolio of 10 molecules. Its GMP standing is certified by ANSM (FR), EMA and MFDS (Korea). Its most recent recorded inspection, by US FDA, closed on 21 January 2022 as VAI.

6
active US DMFs
0
valid CEPs
5
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 21 January 2022 VAI US FDA
  • 10 July 2014 NAI US FDA
  • 25 May 2012 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Cedex, United Arab Emirates Not on file
VAL-DE-REUIL, France Not on file
VAL DE REUIL, France Not on file
Val De Reuil Cedex, France Not on file
France, France 3000538143

What they file, and where

Molecule Regulators Docs
Estradiol SFDA (Saudi Arabia), US FDA 3
Norethisterone US FDA 2
Estradiol Valerate US FDA 1
Relebactam SFDA (Saudi Arabia) 1
Trazodone US FDA 1
エストラジオール吉草酸エステル PMDA (Japan) 1
エストラジオール水和物 PMDA (Japan) 1
トラゾドン塩酸塩 PMDA (Japan) 1
無菌アリピプラゾール水和物 PMDA (Japan) 1
酢酸ノルエチンドロン PMDA (Japan) 1

Also appears on these molecule pages

Estradiol API Norethisterone API Trazodone API

Filings and GMP by regulator

Regulator Filings GMP certificates
EDE (AE) 1 None
ANSM (FR) None 48
EMA None 2
MFDS (Korea) None 2

Scale

Year Revenue Exports Destinations
2024 $115.8M Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Questions about Valdepharm

Does Valdepharm hold a US DMF or a CEP?
Valdepharm holds 6 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Valdepharm FDA-registered?
One site operated by Valdepharm carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Valdepharm's last inspection go?
The most recent inspection on record closed on 21 January 2022 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 3 inspections are on file.
Where does Valdepharm manufacture?
5 registered sites are on record, in United Arab Emirates and France (Cedex, Val-de-reuil and VAL DE Reuil among others). Every site is listed on this page with the register it came from.
What does Valdepharm make?
10 molecules are on record against Valdepharm, including Estradiol, Norethisterone, Estradiol Valerate and Relebactam. Each links through to that molecule's full manufacturer list.
Which regulators recognise Valdepharm's GMP?
Current GMP certificates are on record from ANSM (FR), EMA and MFDS (Korea). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Valdepharm comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 21 January 2022.

Comparable suppliers

Lupin shares 2 molecules “Gedeon Richter” shares 2 molecules Aspen Oss shares 2 molecules Bayer shares 2 molecules Bayer S/A shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported